Related papers: Pricing the COVID-19 Vaccine: A Mathematical Appro…

In response to COVID-19, many countries have mandated social distancing and banned large group gatherings in order to slow down the spread of SARS-CoV-2. These social interventions along with vaccines remain the best way forward to reduce…

Since the onset of the COVID-19 pandemic, vaccines have been an important topic in public discourse. The discussions around vaccines are polarized as some see them as an important measure to end the pandemic, and others are hesitant or find…

As observed during the COVID-19 pandemic, high-income countries, such as the U.S., may exhibit vaccine nationalism during a pandemic: stockpiling doses of vaccine for their own citizens and being reluctant to distribute doses of the vaccine…

Pharmaceutical markets for life-saving therapies combine monopoly power with insurance coverage. We build a tractable sequential game in which a patent-holder chooses the drug price, a profit-maximising insurer sets its premium, and a…

In more than two years since the COVID-19 virus was first detected in China, hundreds of millions of individuals have been infected, and millions have died. Aside from the immediate need for medical solutions (such as vaccines and…

In this study, a vaccine supply chain model is developed considering the humanitarian aspects under uncertain conditions in Iran. There are three main components to supply the required vaccines for vaccination centers that can be designed…

A mathematical model of COVID-19 with minimal compartments is developed. The model is simple enough to fit data on confirmed cases, estimate the hidden infection figure and incorporate the effect of vaccination. With the effect of the new…

The COVID-19 pandemic showed that stocking and procuring vaccines are different from the inventory holding problems of production. The safety of the supply is more important than cost minimization. The Hungarian inventory model is applied…

Despite the astonishing success of COVID-19 vaccines against the virus, a substantial proportion of the population is still hesitant to be vaccinated, undermining governmental efforts to control the virus. To address this problem, we need…

Optimal use and distribution of Covid-19 vaccines involves adjustments of dosing. Due to the rapidly-evolving pandemic, such adjustments often need to be introduced before full efficacy data are available. As demonstrated in other areas of…

In this paper, we look at a database of tweets sorted by various keywords that could indicate the users sentiment towards covid vaccines. With social media becoming such a prevalent source of opinion, sorting and ranking tweets that hold…

Governments across the world are currently facing the task of selecting suitable intervention strategies to cope with the effects of the COVID-19 pandemic. This is a highly challenging task, since harsh measures may result in economic…

Infectious diseases cause more than 13 million deaths a year, worldwide. Globalization, urbanization, climate change, and ecological pressures have significantly increased the risk of a global pandemic. The ongoing COVID-19 pandemic-the…

Clinical trials of a vaccine during an epidemic face particular challenges, such as the pressure to identify an effective vaccine quickly to control the epidemic, and the effect that time-space-varying infection incidence has on the power…

This research presents a review of main datasets that are developed for COVID-19 research. We hope this collection will continue to bring together members of the computing community, biomedical experts, and policymakers in the pursuit of…

Public policy must confront emergencies that evolve in real time and in uncertain directions, yet little is known about the nature of policy response. Here we take the coronavirus pandemic as a global and extraordinarily consequential case,…

Combating the SARS-CoV2 pandemic will require the fast development of effective preventive vaccines. Regulatory agencies may open accelerated approval pathways for vaccines if an immunological marker can be established as a mediator of a…

With the present highly infectious dominant SARS-CoV-2 strain of B1.1.529 or Omicron spreading around the globe, there is concern that the COVID-19 pandemic will not end soon and that it will be a race against time until a more contagious…

Some people did not get the COVID-19 vaccine even though it was offered at no cost. A monetary incentive might lead people to vaccinate, although existing studies have provided different findings about this effect. We investigate how…

This paper introduces a multilingual dataset of COVID-19 vaccine misinformation, consisting of annotated tweets from three middle-income countries: Brazil, Indonesia, and Nigeria. The expertly curated dataset includes annotations for 5,952…